vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and Ubiquiti Inc. (UI). Click either name above to swap in a different company.

Ubiquiti Inc. is the larger business by last-quarter revenue ($814.9M vs $487.7M, roughly 1.7× CLOVER HEALTH INVESTMENTS, CORP.). Ubiquiti Inc. runs the higher net margin — 28.7% vs -10.1%, a 38.8% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs 35.8%). Ubiquiti Inc. produced more free cash flow last quarter ($260.3M vs $-69.0M). Over the past eight quarters, Ubiquiti Inc.'s revenue compounded faster (28.6% CAGR vs 18.6%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

Ubiquiti Inc. is an American technology company founded in San Jose, California, in 2003. Now based in New York City, Ubiquiti manufactures and sells wireless data communication and wired products for enterprises and homes under multiple brand names. On October 13, 2011, Ubiquiti had its initial public offering (IPO) at 7.04 million shares, at $15 per share, raising $30.5 million.

CLOV vs UI — Head-to-Head

Bigger by revenue
UI
UI
1.7× larger
UI
$814.9M
$487.7M
CLOV
Growing faster (revenue YoY)
CLOV
CLOV
+8.9% gap
CLOV
44.7%
35.8%
UI
Higher net margin
UI
UI
38.8% more per $
UI
28.7%
-10.1%
CLOV
More free cash flow
UI
UI
$329.3M more FCF
UI
$260.3M
$-69.0M
CLOV
Faster 2-yr revenue CAGR
UI
UI
Annualised
UI
28.6%
18.6%
CLOV

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
CLOV
CLOV
UI
UI
Revenue
$487.7M
$814.9M
Net Profit
$-49.3M
$233.6M
Gross Margin
45.9%
Operating Margin
-10.1%
35.9%
Net Margin
-10.1%
28.7%
Revenue YoY
44.7%
35.8%
Net Profit YoY
-123.2%
70.8%
EPS (diluted)
$3.86

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
UI
UI
Q4 25
$487.7M
$814.9M
Q3 25
$496.6M
$733.8M
Q2 25
$477.6M
$759.2M
Q1 25
$462.3M
$664.2M
Q4 24
$337.0M
$599.9M
Q3 24
$331.0M
$550.3M
Q2 24
$356.3M
$507.5M
Q1 24
$346.9M
$493.0M
Net Profit
CLOV
CLOV
UI
UI
Q4 25
$-49.3M
$233.6M
Q3 25
$-24.4M
$207.9M
Q2 25
$-10.6M
$266.7M
Q1 25
$-1.3M
$180.4M
Q4 24
$-22.1M
$136.8M
Q3 24
$-9.2M
$128.0M
Q2 24
$7.4M
$103.8M
Q1 24
$-19.2M
$76.3M
Gross Margin
CLOV
CLOV
UI
UI
Q4 25
45.9%
Q3 25
46.0%
Q2 25
45.1%
Q1 25
44.5%
Q4 24
41.2%
Q3 24
24.5%
42.1%
Q2 24
30.3%
40.2%
Q1 24
23.6%
35.3%
Operating Margin
CLOV
CLOV
UI
UI
Q4 25
-10.1%
35.9%
Q3 25
-4.9%
35.7%
Q2 25
-2.2%
34.4%
Q1 25
-0.3%
34.2%
Q4 24
-6.4%
29.8%
Q3 24
-2.7%
30.7%
Q2 24
2.0%
27.3%
Q1 24
-6.5%
22.6%
Net Margin
CLOV
CLOV
UI
UI
Q4 25
-10.1%
28.7%
Q3 25
-4.9%
28.3%
Q2 25
-2.2%
35.1%
Q1 25
-0.3%
27.2%
Q4 24
-6.6%
22.8%
Q3 24
-2.8%
23.3%
Q2 24
2.1%
20.5%
Q1 24
-5.5%
15.5%
EPS (diluted)
CLOV
CLOV
UI
UI
Q4 25
$3.86
Q3 25
$3.43
Q2 25
$4.40
Q1 25
$2.98
Q4 24
$2.26
Q3 24
$2.12
Q2 24
$1.72
Q1 24
$1.26

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
UI
UI
Cash + ST InvestmentsLiquidity on hand
$78.3M
$302.8M
Total DebtLower is stronger
$47.5M
Stockholders' EquityBook value
$308.7M
$1.0B
Total Assets
$541.0M
$1.6B
Debt / EquityLower = less leverage
0.05×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
UI
UI
Q4 25
$78.3M
$302.8M
Q3 25
$177.2M
Q2 25
$149.7M
Q1 25
$151.0M
Q4 24
$194.5M
$133.1M
Q3 24
$288.0M
$165.2M
Q2 24
$254.8M
$126.3M
Q1 24
$208.3M
$102.5M
Total Debt
CLOV
CLOV
UI
UI
Q4 25
$47.5M
Q3 25
$133.8M
Q2 25
$250.0M
Q1 25
$340.0M
Q4 24
$406.3M
Q3 24
$552.5M
Q2 24
$708.1M
Q1 24
$877.5M
Stockholders' Equity
CLOV
CLOV
UI
UI
Q4 25
$308.7M
$1.0B
Q3 25
$340.9M
$828.4M
Q2 25
$344.2M
$668.3M
Q1 25
$336.1M
$436.1M
Q4 24
$341.1M
$290.4M
Q3 24
$342.2M
$188.1M
Q2 24
$324.9M
$95.1M
Q1 24
$292.5M
$25.9M
Total Assets
CLOV
CLOV
UI
UI
Q4 25
$541.0M
$1.6B
Q3 25
$559.7M
$1.5B
Q2 25
$575.0M
$1.5B
Q1 25
$583.7M
$1.3B
Q4 24
$580.7M
$1.2B
Q3 24
$653.0M
$1.2B
Q2 24
$674.2M
$1.2B
Q1 24
$671.8M
$1.2B
Debt / Equity
CLOV
CLOV
UI
UI
Q4 25
0.05×
Q3 25
0.16×
Q2 25
0.37×
Q1 25
0.78×
Q4 24
1.40×
Q3 24
2.94×
Q2 24
7.45×
Q1 24
33.92×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
UI
UI
Operating Cash FlowLast quarter
$-66.9M
$263.9M
Free Cash FlowOCF − Capex
$-69.0M
$260.3M
FCF MarginFCF / Revenue
-14.1%
31.9%
Capex IntensityCapex / Revenue
0.4%
0.4%
Cash ConversionOCF / Net Profit
1.13×
TTM Free Cash FlowTrailing 4 quarters
$-69.2M
$699.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
UI
UI
Q4 25
$-66.9M
$263.9M
Q3 25
$12.1M
$198.5M
Q2 25
$5.4M
$130.4M
Q1 25
$-16.3M
$123.6M
Q4 24
$34.8M
$152.4M
Q3 24
$50.0M
$233.7M
Q2 24
$44.8M
$231.4M
Q1 24
$25.9M
$163.9M
Free Cash Flow
CLOV
CLOV
UI
UI
Q4 25
$-69.0M
$260.3M
Q3 25
$11.4M
$193.3M
Q2 25
$4.8M
$125.2M
Q1 25
$-16.5M
$120.7M
Q4 24
$33.3M
$150.4M
Q3 24
$49.6M
$231.1M
Q2 24
$44.4M
$229.5M
Q1 24
$25.5M
$160.6M
FCF Margin
CLOV
CLOV
UI
UI
Q4 25
-14.1%
31.9%
Q3 25
2.3%
26.3%
Q2 25
1.0%
16.5%
Q1 25
-3.6%
18.2%
Q4 24
9.9%
25.1%
Q3 24
15.0%
42.0%
Q2 24
12.5%
45.2%
Q1 24
7.3%
32.6%
Capex Intensity
CLOV
CLOV
UI
UI
Q4 25
0.4%
0.4%
Q3 25
0.1%
0.7%
Q2 25
0.1%
0.7%
Q1 25
0.0%
0.4%
Q4 24
0.5%
0.3%
Q3 24
0.1%
0.5%
Q2 24
0.1%
0.4%
Q1 24
0.1%
0.7%
Cash Conversion
CLOV
CLOV
UI
UI
Q4 25
1.13×
Q3 25
0.95×
Q2 25
0.49×
Q1 25
0.68×
Q4 24
1.11×
Q3 24
1.83×
Q2 24
6.04×
2.23×
Q1 24
2.15×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

UI
UI

Enterprise Technology$729.0M89%
Service Provider Technology$85.9M11%

Related Comparisons